GWM
IDXX icon

Gibbs Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Gibbs Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$843K Sell
1,500
-444
-23% -$285K 0.11% 181
2025
Q4 		$1.39M Sell
1,944
-278
-13% -$189K 0.34% 61
2025
Q3 		$1.42M Sell
2,222
-357
-14% -$217K 0.32% 65
2025
Q2 		$1.38M Buy
+2,579
New +$1.23M 0.27% 85

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gibbs Wealth Management's IDXX Position: Q1 2026 in Review

Gibbs Wealth Management reduced its Idexx Laboratories (IDXX) stake by 23% in Q1 2026, selling an estimated $285K and leaving 1,500 shares worth $843K. The position accounts for 0.11% of the portfolio, ranked #181.

Gibbs Wealth Management first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.42M in Q3 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Gibbs Wealth Management held 1,500 shares of Idexx Laboratories worth $843K as of Q1 2026.
  • Gibbs Wealth Management sold 444 Idexx Laboratories shares in Q1 2026, an estimated $285K.
  • Idexx Laboratories made up 0.11% of Gibbs Wealth Management's portfolio in Q1 2026, its #181 holding.
  • Gibbs Wealth Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Gibbs Wealth Management's Idexx Laboratories position peaked at $1.42M in Q3 2025.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.